- call +1-201-465-4211
- email sales@mrinsights.biz
Nanoparticles are sub-nanosized colloidal structures composed of synthetic or semi-synthetic polymers. These are used in biotechnology and pharmaceutical sectors for studying biological systems for diagnosing diseases and focusing on treatment at the molecular level. The properties of many conventional materials alter when formed from nanoparticles, the reason being nanoparticles have a greater surface area per weight than larger particles, making them more reactive to other molecules
Scope of the Report:
This report focuses on the Nanoparticles in Biotechnology and Pharmaceuticals in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The nanoparticle segment of the nanotechnology has wider application in pharmaceuticals such as in drug delivery and drug discovery, and in biotechnology such as in studying cellular dynamics and stem cell research. Nanotechnology is growing steadily supported by governments and technology firms making high investments in developing nanotechnology.
Sedentary lifestyles and unbalanced diets, supported by the growing rate of urbanization, are consequent in increased widespread prevalence of chronic diseases. Chronic and lifestyle diseases such as cancer, heart diseases, stroke, chronic respiratory diseases, and diabetes. Nanoparticles are utilized to determine the biological alterations of peptide and protein fragments. This diagnosis aids in developing new treatment solutions to treat the growing incidences of chronic diseases. The increasing prevalence of chronic diseases is identified to be one of the key trends having a positive impact on the nanoparticles market in biotechnology and pharmaceutical sectors.
The worldwide market for Nanoparticles in Biotechnology and Pharmaceuticals is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Roche
GE Healthcare
Merck
Novartis
AMAG Pharmaceuticals
Amgen
Bausch & Lomb
Biogen
Celgene
Gilead
Ipsen
Leadiant Biosciences
nanoComposix
Pacira Pharmaceuticals
Pfizer
Shire
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Fullerenes
Liquid Crystals
Liposomes
Nanoshells
Quantum dots
Superparamagnetic nanoparticles
Market Segment by Applications, can be divided into
Biotechnology
Pharmaceutical
There are 15 Chapters to deeply display the global Nanoparticles in Biotechnology and Pharmaceuticals market.
Chapter 1, to describe Nanoparticles in Biotechnology and Pharmaceuticals Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Nanoparticles in Biotechnology and Pharmaceuticals, with sales, revenue, and price of Nanoparticles in Biotechnology and Pharmaceuticals, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Nanoparticles in Biotechnology and Pharmaceuticals, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Nanoparticles in Biotechnology and Pharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Nanoparticles in Biotechnology and Pharmaceuticals sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Nanoparticles in Biotechnology and Pharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Fullerenes
1.2.2 Liquid Crystals
1.2.3 Liposomes
1.2.4 Nanoshells
1.2.5 Quantum dots
1.2.6 Superparamagnetic nanoparticles
1.3 Market Analysis by Applications
1.3.1 Biotechnology
1.3.2 Pharmaceutical
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 GE Healthcare
2.2.1 Business Overview
2.2.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GE Healthcare Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
2.3.1 Business Overview
2.3.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 AMAG Pharmaceuticals
2.5.1 Business Overview
2.5.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AMAG Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Amgen
2.6.1 Business Overview
2.6.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Amgen Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bausch & Lomb
2.7.1 Business Overview
2.7.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bausch & Lomb Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Biogen
2.8.1 Business Overview
2.8.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Biogen Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Celgene
2.9.1 Business Overview
2.9.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Celgene Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Gilead
2.10.1 Business Overview
2.10.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Gilead Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Ipsen
2.11.1 Business Overview
2.11.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Ipsen Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Leadiant Biosciences
2.12.1 Business Overview
2.12.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Leadiant Biosciences Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 nanoComposix
2.13.1 Business Overview
2.13.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 nanoComposix Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Pacira Pharmaceuticals
2.14.1 Business Overview
2.14.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Pacira Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Pfizer
2.15.1 Business Overview
2.15.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Pfizer Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Shire
2.16.1 Business Overview
2.16.2 Nanoparticles in Biotechnology and Pharmaceuticals Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Shire Nanoparticles in Biotechnology and Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Nanoparticles in Biotechnology and Pharmaceuticals Manufacturer Market Share in 2017
3.3.2 Top 6 Nanoparticles in Biotechnology and Pharmaceuticals Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis by Regions
4.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue and Market Share by Regions
4.1.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Regions (2013-2018)
4.1.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Market Share by Regions (2013-2018)
4.2 North America Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
4.3 Europe Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
4.5 South America Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
5 North America Nanoparticles in Biotechnology and Pharmaceuticals by Countries
5.1 North America Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue and Market Share by Countries
5.1.1 North America Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Countries (2013-2018)
5.1.2 North America Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Market Share by Countries (2013-2018)
5.2 United States Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
5.3 Canada Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
5.4 Mexico Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
6 Europe Nanoparticles in Biotechnology and Pharmaceuticals by Countries
6.1 Europe Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue and Market Share by Countries
6.1.1 Europe Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Market Share by Countries (2013-2018)
6.2 Germany Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
6.3 UK Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
6.4 France Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
6.5 Russia Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
6.6 Italy Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
7 Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals by Countries
7.1 Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Market Share by Countries (2013-2018)
7.2 China Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
7.3 Japan Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
7.4 Korea Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
7.5 India Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
8 South America Nanoparticles in Biotechnology and Pharmaceuticals by Countries
8.1 South America Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue and Market Share by Countries
8.1.1 South America Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Countries (2013-2018)
8.1.2 South America Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
8.3 Argentina Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
8.4 Colombia Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
9 Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals by Countries
9.1 Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
9.3 UAE Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
9.4 Egypt Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
9.5 Nigeria Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
9.6 South Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate (2013-2018)
10 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Segment by Type
10.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Type (2013-2018)
10.1.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Market Share by Type (2013-2018)
10.2 Fullerenes Sales Growth and Price
10.2.1 Global Fullerenes Sales Growth (2013-2018)
10.2.2 Global Fullerenes Price (2013-2018)
10.3 Liquid Crystals Sales Growth and Price
10.3.1 Global Liquid Crystals Sales Growth (2013-2018)
10.3.2 Global Liquid Crystals Price (2013-2018)
10.4 Liposomes Sales Growth and Price
10.4.1 Global Liposomes Sales Growth (2013-2018)
10.4.2 Global Liposomes Price (2013-2018)
10.5 Nanoshells Sales Growth and Price
10.5.1 Global Nanoshells Sales Growth (2013-2018)
10.5.2 Global Nanoshells Price (2013-2018)
10.6 Quantum dots Sales Growth and Price
10.6.1 Global Quantum dots Sales Growth (2013-2018)
10.6.2 Global Quantum dots Price (2013-2018)
10.7 Superparamagnetic nanoparticles Sales Growth and Price
10.7.1 Global Superparamagnetic nanoparticles Sales Growth (2013-2018)
10.7.2 Global Superparamagnetic nanoparticles Price (2013-2018)
11 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Segment by Application
11.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share by Application (2013-2018)
11.2 Biotechnology Sales Growth (2013-2018)
11.3 Pharmaceutical Sales Growth (2013-2018)
12 Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast (2018-2023)
12.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue and Growth Rate (2018-2023)
12.2 Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast by Regions (2018-2023)
12.2.1 North America Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast (2018-2023)
12.2.2 Europe Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast (2018-2023)
12.2.3 Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast (2018-2023)
12.2.4 South America Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast (2018-2023)
12.2.5 Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast (2018-2023)
12.3 Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast by Type (2018-2023)
12.3.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Forecast by Type (2018-2023)
12.3.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Share Forecast by Type (2018-2023)
12.4 Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast by Application (2018-2023)
12.4.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Forecast by Application (2018-2023)
12.4.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Nanoparticles in Biotechnology and Pharmaceuticals Picture
Table Product Specifications of Nanoparticles in Biotechnology and Pharmaceuticals
Figure Global Sales Mar
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
